Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/14/2025

Contraindications for Probiotics

Primary Contraindications

  • The World Health Organization recommends that immunosuppressed patients should not receive probiotics due to documented risk of invasive infection from probiotic organisms themselves 1, 2
  • The American Gastroenterological Association suggests that patients with severe immunosuppression from any cause, such as HIV with low CD4 counts, chemotherapy, or immunosuppressive medications, should avoid probiotics 3
  • The risk of probiotic-induced sepsis outweighs potential benefits in immunocompromised populations, according to the World Journal of Emergency Surgery 1

Critical Illness and Severe Debilitation

  • The Society of Critical Care Medicine advises that severely debilitated patients should avoid probiotics due to increased infection risk 2
  • Patients at risk of bacteremia or fungemia from any cause should not receive probiotics, as recommended by the World Journal of Emergency Surgery 2

Structural Gastrointestinal and Cardiac Abnormalities

  • The American Heart Association states that patients with damaged intestinal mucosa are at increased risk for bacterial translocation and systemic infection 3
  • The American College of Cardiology recommends that patients with central venous catheters face higher risk of line-associated infections and should exercise caution with probiotics 3
  • Cardiac valvular disease represents a contraindication due to risk of endocarditis from bacteremia, according to the American College of Cardiology 3

Disease-Specific Considerations

  • The European Crohn’s and Colitis Organisation notes that specific strains of probiotics may have benefit in ulcerative colitis and pouchitis, but not in Crohn's disease 4

Important Clinical Caveats

  • The Infectious Diseases Society of America warns that Saccharomyces boulardii carries particular risk of fungemia in vulnerable patients and requires extra caution 3
  • The American Geriatrics Society recommends that patients on warfarin require increased INR monitoring when probiotics are initiated, though documented clinically significant interactions are rare 3

General Principles

  • The fundamental principle is that probiotics should only be used in immunocompetent patients without severe underlying illness, as the risk-benefit ratio becomes unfavorable when host defenses are compromised, according to the World Journal of Emergency Surgery and the American Gastroenterological Association 1, 2, 3